Viewing Study NCT00472433


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-27 @ 3:06 AM
Study NCT ID: NCT00472433
Status: TERMINATED
Last Update Posted: 2009-06-22
First Post: 2007-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
Sponsor: Phramongkutklao College of Medicine and Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-03
Start Date Type: None
Primary Completion Date: 2009-05
Primary Completion Date Type: ACTUAL
Completion Date: 2009-05
Completion Date Type: ACTUAL
First Submit Date: 2007-04-25
First Submit QC Date: None
Study First Post Date: 2007-05-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-06-18
Last Update Post Date: 2009-06-22
Last Update Post Date Type: ESTIMATED